Fractionation of an Extract of Pluchea odorata Separates a Property Indicative for the Induction of Cell Plasticity from One That Inhibits a Neoplastic Phenotype

Autoren:Seelinger, Mareike (Medizinische Universität Wien); McKinnon, Ruxandra; Giessrigl, Benedikt (Universitätsklinik, Medizinische Universität Wien); Unger, Christine (Medizinische Universität Wien); Bauer, Sabine (Universitätsklinik, Medizinische Universität Wien); Wagner, Karl-Heinz; Fritzer-Szekeres, Monika (Medizinische Universität Wien); Szekeres, Thomas (Medizinische Universität Wien); Diaz, Rene (International Institute for Ethnobiological and Maya-Research and Ethnobotany); Tut, Foster M. (International Institute for Ethnobiological and Maya-Research and Ethnobotany); Frisch, Richard (International Institute for Ethnobiological and Maya-Research and Ethnobotany); Feistel, Bjorn (Finzelberg GmbH & Co KG); Kopp, Brigitte; Krupitza, Georg (Medizinische Universität Wien)
Abstrakt:Introduction. Several studies demonstrated that anti-inflammatory remedies exhibit excellent anti-neoplastic properties. An extract of Pluchea odorata (Asteraceae), which is used for wound healing and against inflammatory conditions, was fractionated and properties correlating to anti-neoplastic and wound healing effects were separated. Methods. Up to six fractionation steps using silica gel, Sephadex columns, and distinct solvent systems were used, and eluted fractions were analysed by thin layer chromatography, apoptosis, and proliferation assays. The expression of oncogenes and proteins regulating cell migration was investigated by immunoblotting after treating HL60 cells with the most active fractions. Results. Sequential fractionations enriched anti-neoplastic activities which suppressed oncogene expression of JunB, c-Jun, c-Myc, and Stat3. Furthermore, a fraction (F4.6.3) inducing or keeping up expression of the mobility markers MYPT, ROCK1, and paxillin could be separated from another fraction (F4.3.7), which inhibited these markers. Conclusions. Wound healing builds up scar or specific tissue, and hence, compounds enhancing cell migration support this process. In contrast, successful anti-neoplastic therapy combats tumour progression, and thus, suppression of cell migration is mandatory.
Journaltitel:Evidence Based Complementary and Alternative Medicine
Peer reviewed:true
Digital Object Identifier (DOI):
Bibliographische Notiz:***148064.28***